8-K: Astrana Health Completes Prospect Health Acquisition at Reduced Price, Updates 2025 Financial Guidance

Astrana Health, Inc. has successfully closed its acquisition of Prospect Health for a reduced purchase price of $707.9 million, updating its full-year 2025 revenue and adjusted EBITDA guidance to reflect the integration.

Summary

• Astrana Health, Inc. completed the acquisition of all outstanding equity interests of Alta Newport Hospital, LLC (d/b/a Foothill Regional Medical Center) and Prospect Health Plan, Inc., and substantially all assets of certain direct and indirect subsidiaries of PHP Holdings, LLC (collectively referred to as Prospect Health) on July 1, 2025.
• The final aggregate purchase price paid at closing was $707.9 million in cash, a reduction from the originally announced $745.0 million.
• The acquisition was financed using $707.9 million from a five-year delayed draw term loan credit facility of up to $745 million, provided by a syndicate of banks led by Truist Bank.
• Prospect Health is described as a value-based, integrated care delivery network with over 11,000 providers across Southern California, Texas, Arizona, and Rhode Island, serving approximately 600,000 members across Medicare Advantage, Medicaid, and Commercial lines of business.
• Astrana Health updated its full-year 2025 guidance to reflect the half-year contribution from Prospect Health, projecting total revenue between $3.1 billion and $3.3 billion and adjusted EBITDA between $215 million and $225 million.
• Prospect Health is expected to contribute approximately $1.2 billion in total revenue and $81 million in adjusted EBITDA on a full-year basis, as previously announced.
• Astrana Health anticipates realizing between $12 million to $15 million of synergies over the next 12 to 18 months.
• Following the transaction, Astrana Health will have approximately $700 million of net debt on its consolidated balance sheet.
• Management remains committed to reducing the company's net leverage ratio to below 2.5x over the next 12 to 18 months.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to the successful completion of a significant acquisition, a reduction in the purchase price, and reaffirmed/updated guidance that incorporates the new asset's expected contributions and synergies. Management expresses excitement and commitment to future financial goals.

Positives

• Successful completion of the strategic acquisition of Prospect Health, which is expected to deepen Astrana's capabilities in providing high-quality and high-value care.
• The final purchase price was reduced to $707.9 million from the originally announced $745.0 million, underscoring a commitment to disciplined capital deployment.
• Anticipated synergies of $12 million to $15 million are expected to be realized over the next 12 to 18 months.
• Prospect Health is projected to contribute significantly to Astrana's financials, with an expected $1.2 billion in total revenue and $81 million in adjusted EBITDA on a full-year basis.
• Management has a clear commitment to reducing the company's net leverage ratio to below 2.5x over the next 12 to 18 months.

Risks

• Diversion of management's attention from ongoing business operations due to the Transaction.
• Potential increase in the amount of costs, fees, expenses, and other charges related to the Transaction.
• Risks of disruption to Astrana Health's business as a result of the acquisition closing.
• Potential difficulties in employee retention as a result of the Transaction.
• Uncertainty regarding Astrana Health's ability to pay the interest and principal on the Second Amended and Restated Credit Agreement.
• Uncertainty regarding Astrana Health's ability to implement business plans, forecasts, and other expectations after closing, realize the intended benefits of the Transaction, and identify and realize additional opportunities.
• Preliminary financial results and forecasts are based on assumptions and estimates, are inherently uncertain and subjective, and there is no assurance that projected results will be realized or that actual results will not be higher or lower than projected.

Future Outlook

Astrana Health updated its full-year 2025 guidance to reflect the half-year contribution from the Prospect Health acquisition, projecting total revenue between $3.1 billion and $3.3 billion and adjusted EBITDA between $215 million and $225 million. The company also anticipates realizing $12 million to $15 million in synergies over the next 12 to 18 months and is committed to reducing its net leverage ratio to below 2.5x within the same timeframe.

Management Comments

• We are excited to welcome Prospect Healths physicians, providers, and team members to Astrana Health.
• Together, we will further accelerate our mission to drive consistent, coordinated, high-quality patient outcomes at scale, ultimately driving greater value across the healthcare ecosystem.

Industry Context

The acquisition of Prospect Health by Astrana Health aligns with the broader healthcare industry trend towards value-based care models and integrated care delivery networks. By expanding its network of providers and members, Astrana Health is positioning itself to enhance its capabilities in delivering coordinated, high-quality care, which is crucial for improving patient outcomes and driving efficiency in the evolving healthcare ecosystem. This move strengthens Astrana's presence in key regions and its ability to manage diverse patient populations across various payer lines of business.

Stakeholder Impact

• Shareholders: Potential for increased value through strategic growth, synergies, and disciplined capital deployment, but also exposure to integration risks and increased debt.
• Employees: Prospect Health's physicians, providers, and team members are welcomed to Astrana Health, indicating integration and potential changes in corporate culture or operations.
• Patients: The acquisition aims to deepen capabilities in providing access to high-quality and high-value care, potentially improving patient outcomes and experiences.

Next Steps

• Realizing $12 million to $15 million of synergies over the next 12 to 18 months.
• Reducing the company's net leverage ratio to below 2.5x over the next 12 to 18 months.
• Filing required financial statements of businesses acquired and pro forma financial information with the SEC by amendment to the Current Report no later than 71 days after the filing date.

Key Dates

Keywords

Healthcare, Acquisition, Merger, Value-based care, Integrated care, Health plan, Medical group, Financial guidance, Revenue, EBITDA, Debt, Synergies, SEC filing, 8-K, Astrana Health, Prospect Health